Amanda L Blackford1, Albert W Wu2,3, Claire Snyder1,2,3. 1. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. 2. Johns Hopkins Bloomberg School of Public Health. 3. Johns Hopkins School of Medicine, Baltimore, MD.
Abstract
INTRODUCTION: We have used several methods to aid in the interpretation of patient-reported outcome (PRO) scores, and to suggest recommendations for acting on them, both within the PatientViewpoint system and in work done since. METHODS FOR INTERPRETING PRO SCORES: For identifying possibly concerning change scores, PatientViewpoint uses questionnaires' minimally important differences or score worsening >½ SD. For poor scores in absolute terms, PatientViewpoint primarily uses distributions based on normative data (eg, worst quartile, >2 SD from the mean). To advance methods for score interpretation, we explored using needs assessments to identify health-related quality-of-life scores associated with unmet needs and requiring follow-up. We also investigated the ability of PRO scores to predict patients' most bothersome issues. METHODS FOR ADDRESSING PRO RESULTS: To develop suggestions for addressing issues identified by PRO questionnaires, we conducted a targeted literature review, interviewed experts from different disciplines, developed draft recommendations based on the literature and interviews, and finalized the recommendations in a consensus meeting with all experts. DISCUSSION: The needs assessment method requires strongly correlated content in the needs assessment and health-related quality-of-life questionnaire. Additional research is needed to explore using the worst scores in absolute terms to identify patients' most bothersome issues. The approach described for developing suggestions for addressing PRO results focuses on local resources and is best-suited for a local context. KEY POINTS: A combination of pragmatic solutions and exploratory research can inform interpreting and acting on PRO scores.
INTRODUCTION: We have used several methods to aid in the interpretation of patient-reported outcome (PRO) scores, and to suggest recommendations for acting on them, both within the PatientViewpoint system and in work done since. METHODS FOR INTERPRETING PRO SCORES: For identifying possibly concerning change scores, PatientViewpoint uses questionnaires' minimally important differences or score worsening >½ SD. For poor scores in absolute terms, PatientViewpoint primarily uses distributions based on normative data (eg, worst quartile, >2 SD from the mean). To advance methods for score interpretation, we explored using needs assessments to identify health-related quality-of-life scores associated with unmet needs and requiring follow-up. We also investigated the ability of PRO scores to predict patients' most bothersome issues. METHODS FOR ADDRESSING PRO RESULTS: To develop suggestions for addressing issues identified by PRO questionnaires, we conducted a targeted literature review, interviewed experts from different disciplines, developed draft recommendations based on the literature and interviews, and finalized the recommendations in a consensus meeting with all experts. DISCUSSION: The needs assessment method requires strongly correlated content in the needs assessment and health-related quality-of-life questionnaire. Additional research is needed to explore using the worst scores in absolute terms to identify patients' most bothersome issues. The approach described for developing suggestions for addressing PRO results focuses on local resources and is best-suited for a local context. KEY POINTS: A combination of pragmatic solutions and exploratory research can inform interpreting and acting on PRO scores.
Authors: Claire F Snyder; Amanda L Blackford; Julie R Brahmer; Michael A Carducci; Roberto Pili; Vered Stearns; Antonio C Wolff; Sydney M Dy; Albert W Wu Journal: Qual Life Res Date: 2010-03-26 Impact factor: 4.147
Authors: Claire F Snyder; Amanda L Blackford; Neil K Aaronson; Symone B Detmar; Michael A Carducci; Michael D Brundage; Albert W Wu Journal: J Clin Oncol Date: 2011-02-22 Impact factor: 44.544
Authors: John T Maringwa; Chantal Quinten; Madeleine King; Jolie Ringash; David Osoba; Corneel Coens; Francesca Martinelli; Jurgen Vercauteren; Charles S Cleeland; Henning Flechtner; Carolyn Gotay; Eva Greimel; Martin J Taphoorn; Bryce B Reeve; Joseph Schmucker-Von Koch; Joachim Weis; Egbert F Smit; Jan P van Meerbeeck; Andrew Bottomley Journal: Support Care Cancer Date: 2010-10-01 Impact factor: 3.603
Authors: Claire F Snyder; Amanda L Blackford; Antonio C Wolff; Michael A Carducci; Joseph M Herman; Albert W Wu Journal: Psychooncology Date: 2012-04-30 Impact factor: 3.894
Authors: Heather S L Jim; Aasha I Hoogland; Naomi C Brownstein; Anna Barata; Adam P Dicker; Hans Knoop; Brian D Gonzalez; Randa Perkins; Dana Rollison; Scott M Gilbert; Ronica Nanda; Anders Berglund; Ross Mitchell; Peter A S Johnstone Journal: CA Cancer J Clin Date: 2020-04-20 Impact factor: 508.702
Authors: Janet H Van Cleave; Mei R Fu; Antonia V Bennett; Catherine Concert; Ann Riccobene; Anh Tran; Allison Most; Maria Kamberi; Jacqueline Mojica; Justin Savitski; Elise Kusche; Mark S Persky; Zujun Li; Adam S Jacobson; Kenneth S Hu; Michael J Persky; Eva Liang; Patricia M Corby; Brian L Egleston Journal: Mhealth Date: 2021-01-20
Authors: Yiman Wang; Jaapjan D Snoep; Marc H Hemmelder; Koen E A van der Bogt; Willem Jan W Bos; Paul J M van der Boog; Friedo W Dekker; Aiko P J de Vries; Yvette Meuleman Journal: Clin Kidney J Date: 2021-01-20
Authors: Talya Salz; Jamie S Ostroff; Chandylen L Nightingale; Thomas M Atkinson; Eleanor C Davidson; Sankeerth R Jinna; Anuja Kriplani; Glenn J Lesser; Kathleen A Lynch; Deborah K Mayer; Kevin C Oeffinger; Sujata Patil; Andrew L Salner; Kathryn E Weaver Journal: Contemp Clin Trials Date: 2021-05-21 Impact factor: 2.261